New hope for Hard-to-Treat cancers: first human trial launches
Disease control
Recruiting now
This early-stage study tests a new drug called PHST001, alone or with chemotherapy, in adults with advanced solid tumors that have stopped responding to standard treatments. The main goals are to check safety and find the best dose. About 272 people with cancers like ovarian, end…
Phase: PHASE1 • Sponsor: Pheast Therapeutics • Aim: Disease control
Last updated May 19, 2026 11:47 UTC